Mesirow Financial Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.1M Buy
15,088
+298
+2% +$304K 0.28% 81
2026
Q1
$13.6M Buy
14,790
+782
+6% +$793K 0.22% 102
2025
Q4
$15.1M Sell
14,008
-1,487
-10% -$1.42M 0.31% 74
2025
Q3
$11.8M Buy
15,495
+220
+1% +$164K 0.21% 100
2025
Q2
$11.9M Sell
15,275
-396
-3% -$308K 0.23% 96
2025
Q1
$12.9M Sell
15,671
-375
-2% -$312K 0.25% 91
2024
Q4
$12.4M Buy
16,046
+43
+0.3% +$35.6K 0.25% 89
2024
Q3
$14.2M Buy
16,003
+111
+0.7% +$99.8K 0.27% 82
2024
Q2
$14.4M Sell
15,892
-228
-1% -$182K 0.32% 76
2024
Q1
$12.5M Buy
16,120
+1,548
+11% +$1.1M 0.29% 86
2023
Q4
$6.55M Buy
+14,572
New +$8.51M 0.24% 84

Other funds holding LLY

Mesirow Financial Investment Management's LLY Position: Q2 2026 in Review

Mesirow Financial Investment Management increased its Eli Lilly (LLY) stake by 2% in Q2 2026, buying an estimated $304K and bringing the position to 15,088 shares worth $18.1M. The position accounts for 0.28% of the portfolio, ranked #81.

Mesirow Financial Investment Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mesirow Financial Investment Management held 15,088 shares of Eli Lilly worth $18.1M as of Q2 2026.
  • Mesirow Financial Investment Management bought 298 Eli Lilly shares in Q2 2026, an estimated $304K.
  • Eli Lilly made up 0.28% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #81 holding.
  • Mesirow Financial Investment Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.